Employees: 02 (2023.0)Legal category: 5485Size: PMECreation date: 2015-07-29 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: SAINT-DIDIER (84210), Vaucluse
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE LLACER : revenue, balance sheet and financial ratios
SELARL PHARMACIE LLACER is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in SAINT-DIDIER (84210),
this company of category PME
shows in 2024 a net income positive of 15 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE LLACER (SIREN 812822849)
Indicator
2024
2023
2022
2021
2020
2019
2018
2016
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
14 924 €
47 224 €
72 256 €
58 503 €
47 795 €
55 090 €
61 499 €
-24 646 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE LLACER generates positive net income of 15 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
14 924 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 78%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 49%. This high autonomy means the company finances most of its assets through equity, a sign of strength.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
78.014%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
48.516%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2018
2019
2020
2021
2022
2023
2024
Debt ratio
207.993
371.979
269.599
207.251
155.46
115.27
91.482
78.014
Financial autonomy
6.339
18.141
23.145
28.509
33.781
39.779
45.255
48.516
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
78.012024
2022
2023
2024
Q1: 16.46
Med: 58.48
Q3: 154.77
Average
In 2024, the debt ratio of SELARL PHARMACIE LLACER (78.01) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
48.52%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average+8 pts over 3 years
In 2024, the financial autonomy of SELARL PHARMACIE LLACER (48.5%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 121.00. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
156.957
148.893
149.003
153.662
145.492
148.896
146.458
121.001
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
121.02024
2022
2023
2024
Q1: 129.46
Med: 182.14
Q3: 260.79
Watch
In 2024, the liquidity ratio of SELARL PHARMACIE LLACER (121.00) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SELARL PHARMACIE LLACER in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE LLACER is estimated at
208 350 €
(range 145 091€ - 311 703€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
145k€208k€311k€
208 350 €Range: 145 091€ - 311 703€
NAF 5 année 2024
Valuation method used
Net Income Multiple
14 924 €
×
14.0x
=208 350 €
Range: 145 092€ - 311 704€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE LLACER with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE LLACER
What is the revenue of SELARL PHARMACIE LLACER ?
The revenue of SELARL PHARMACIE LLACER is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE LLACER profitable?
Yes, SELARL PHARMACIE LLACER generated a net profit of 15 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE LLACER ?
The headquarters of SELARL PHARMACIE LLACER is located in SAINT-DIDIER (84210), in the department Vaucluse.
Where to find the tax return of SELARL PHARMACIE LLACER ?
The tax return of SELARL PHARMACIE LLACER is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE LLACER operate?
SELARL PHARMACIE LLACER operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart